Ketorolac Injection Industry Research Report 2023
Highlights
The global Ketorolac Injection market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Ketorolac Injection is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Ketorolac Injection is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The major global manufacturers of Ketorolac Injection include Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), Sagent Pharmaceuticals, Hikma, Lunan Pharma, Alvogen, Chengdu Brilliant Pharmaceuticals and Athenex, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Ketorolac Injection in Hospital is estimated to increase from $ million in 2022 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, 15mg/ml, which accounted for % of the global market of Ketorolac Injection in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2023 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ketorolac Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ketorolac Injection.
The Ketorolac Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Ketorolac Injection market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ketorolac Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Ketorolac Injection type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Ketorolac Injection are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Ketorolac Injection segment by Concentration
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Ketorolac Injection market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Ketorolac Injection market.
Ketorolac Injection segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Ketorolac Injection market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ketorolac Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Ketorolac Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Ketorolac Injection industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ketorolac Injection.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ketorolac Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ketorolac Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ketorolac Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by concentration, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
The global Ketorolac Injection market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Ketorolac Injection is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Ketorolac Injection is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The major global manufacturers of Ketorolac Injection include Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), Sagent Pharmaceuticals, Hikma, Lunan Pharma, Alvogen, Chengdu Brilliant Pharmaceuticals and Athenex, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Ketorolac Injection in Hospital is estimated to increase from $ million in 2022 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, 15mg/ml, which accounted for % of the global market of Ketorolac Injection in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2023 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ketorolac Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ketorolac Injection.
The Ketorolac Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Ketorolac Injection market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ketorolac Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Pfizer
- Fresenius Kabi
- Fosun Pharma (Gland Pharma)
- Sagent Pharmaceuticals
- Hikma
- Lunan Pharma
- Alvogen
- Chengdu Brilliant Pharmaceuticals
- Athenex
- Sichuan Medcalo
- Julphar Bangladesh Ltd.
- Yung Shin Pharm
- Tianjin Chase Sun Pharmaceutical
- ZISKA Pharmaceuticals
Global markets are presented by Ketorolac Injection type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Ketorolac Injection are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Ketorolac Injection segment by Concentration
- 15mg/ml
- 30mg/ml
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Ketorolac Injection market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Ketorolac Injection market.
Ketorolac Injection segment by Application
- Hospital
- Clinics
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Ketorolac Injection market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ketorolac Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Ketorolac Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Ketorolac Injection industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ketorolac Injection.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ketorolac Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ketorolac Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ketorolac Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by concentration, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Ketorolac Injection Market Size (2018-2029) & (US$ Million)
2.2.2 Global Ketorolac Injection Sales (2018-2029)
2.2.3 Global Ketorolac Injection Market Average Price (2018-2029)
2.3 Ketorolac Injection by Concentration
2.3.1 Market Value Comparison by Concentration (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 15mg/ml
1.2.3 30mg/ml
2.4 Ketorolac Injection by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Hospital
2.4.3 Clinics
2.4.4 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Ketorolac Injection Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Ketorolac Injection Sales (K Units) of Manufacturers (2018-2023)
3.3 Global Ketorolac Injection Revenue of Manufacturers (2018-2023)
3.4 Global Ketorolac Injection Average Price by Manufacturers (2018-2023)
3.5 Global Ketorolac Injection Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Ketorolac Injection, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Ketorolac Injection, Product Type & Application
3.8 Global Manufacturers of Ketorolac Injection, Date of Enter into This Industry
3.9 Global Ketorolac Injection Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Pfizer
4.1.1 Pfizer Company Information
4.1.2 Pfizer Business Overview
4.1.3 Pfizer Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Pfizer Ketorolac Injection Product Portfolio
4.1.5 Pfizer Recent Developments
4.2 Fresenius Kabi
4.2.1 Fresenius Kabi Company Information
4.2.2 Fresenius Kabi Business Overview
4.2.3 Fresenius Kabi Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Fresenius Kabi Ketorolac Injection Product Portfolio
4.2.5 Fresenius Kabi Recent Developments
4.3 Fosun Pharma (Gland Pharma)
4.3.1 Fosun Pharma (Gland Pharma) Company Information
4.3.2 Fosun Pharma (Gland Pharma) Business Overview
4.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio
4.3.5 Fosun Pharma (Gland Pharma) Recent Developments
4.4 Sagent Pharmaceuticals
4.4.1 Sagent Pharmaceuticals Company Information
4.4.2 Sagent Pharmaceuticals Business Overview
4.4.3 Sagent Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Sagent Pharmaceuticals Ketorolac Injection Product Portfolio
4.4.5 Sagent Pharmaceuticals Recent Developments
4.5 Hikma
4.5.1 Hikma Company Information
4.5.2 Hikma Business Overview
4.5.3 Hikma Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hikma Ketorolac Injection Product Portfolio
6.5.5 Hikma Recent Developments
4.6 Lunan Pharma
4.6.1 Lunan Pharma Company Information
4.6.2 Lunan Pharma Business Overview
4.6.3 Lunan Pharma Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Lunan Pharma Ketorolac Injection Product Portfolio
4.6.5 Lunan Pharma Recent Developments
4.7 Alvogen
4.7.1 Alvogen Company Information
4.7.2 Alvogen Business Overview
4.7.3 Alvogen Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Alvogen Ketorolac Injection Product Portfolio
4.7.5 Alvogen Recent Developments
6.8 Chengdu Brilliant Pharmaceuticals
4.8.1 Chengdu Brilliant Pharmaceuticals Company Information
4.8.2 Chengdu Brilliant Pharmaceuticals Business Overview
4.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio
4.8.5 Chengdu Brilliant Pharmaceuticals Recent Developments
4.9 Athenex
4.9.1 Athenex Company Information
4.9.2 Athenex Business Overview
4.9.3 Athenex Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Athenex Ketorolac Injection Product Portfolio
4.9.5 Athenex Recent Developments
4.10 Sichuan Medcalo
4.10.1 Sichuan Medcalo Company Information
4.10.2 Sichuan Medcalo Business Overview
4.10.3 Sichuan Medcalo Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Sichuan Medcalo Ketorolac Injection Product Portfolio
4.10.5 Sichuan Medcalo Recent Developments
6.11 Julphar Bangladesh Ltd.
6.11.1 Julphar Bangladesh Ltd. Company Information
6.11.2 Julphar Bangladesh Ltd. Ketorolac Injection Business Overview
6.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio
6.11.5 Julphar Bangladesh Ltd. Recent Developments
6.12 Yung Shin Pharm
6.12.1 Yung Shin Pharm Company Information
6.12.2 Yung Shin Pharm Ketorolac Injection Business Overview
6.12.3 Yung Shin Pharm Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Yung Shin Pharm Ketorolac Injection Product Portfolio
6.12.5 Yung Shin Pharm Recent Developments
6.13 Tianjin Chase Sun Pharmaceutical
6.13.1 Tianjin Chase Sun Pharmaceutical Company Information
6.13.2 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Business Overview
6.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio
6.13.5 Tianjin Chase Sun Pharmaceutical Recent Developments
6.14 ZISKA Pharmaceuticals
6.14.1 ZISKA Pharmaceuticals Company Information
6.14.2 ZISKA Pharmaceuticals Ketorolac Injection Business Overview
6.14.3 ZISKA Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio
6.14.5 ZISKA Pharmaceuticals Recent Developments
5 GLOBAL KETOROLAC INJECTION MARKET SCENARIO BY REGION
5.1 Global Ketorolac Injection Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Ketorolac Injection Sales by Region: 2018-2029
5.2.1 Global Ketorolac Injection Sales by Region: 2018-2023
5.2.2 Global Ketorolac Injection Sales by Region: 2024-2029
5.3 Global Ketorolac Injection Revenue by Region: 2018-2029
5.3.1 Global Ketorolac Injection Revenue by Region: 2018-2023
5.3.2 Global Ketorolac Injection Revenue by Region: 2024-2029
5.4 North America Ketorolac Injection Market Facts & Figures by Country
5.4.1 North America Ketorolac Injection Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Ketorolac Injection Sales by Country (2018-2029)
5.4.3 North America Ketorolac Injection Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Ketorolac Injection Market Facts & Figures by Country
5.5.1 Europe Ketorolac Injection Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Ketorolac Injection Sales by Country (2018-2029)
5.5.3 Europe Ketorolac Injection Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Ketorolac Injection Market Facts & Figures by Country
5.6.1 Asia Pacific Ketorolac Injection Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Ketorolac Injection Sales by Country (2018-2029)
5.6.3 Asia Pacific Ketorolac Injection Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Ketorolac Injection Market Facts & Figures by Country
5.7.1 Latin America Ketorolac Injection Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Ketorolac Injection Sales by Country (2018-2029)
5.7.3 Latin America Ketorolac Injection Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Ketorolac Injection Market Facts & Figures by Country
5.8.1 Middle East and Africa Ketorolac Injection Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Ketorolac Injection Sales by Country (2018-2029)
5.8.3 Middle East and Africa Ketorolac Injection Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY CONCENTRATION
6.1 Global Ketorolac Injection Sales by Concentration (2018-2029)
6.1.1 Global Ketorolac Injection Sales by Concentration (2018-2029) & (K Units)
6.1.2 Global Ketorolac Injection Sales Market Share by Concentration (2018-2029)
6.2 Global Ketorolac Injection Revenue by Concentration (2018-2029)
6.2.1 Global Ketorolac Injection Sales by Concentration (2018-2029) & (US$ Million)
6.2.2 Global Ketorolac Injection Revenue Market Share by Concentration (2018-2029)
6.3 Global Ketorolac Injection Price by Concentration (2018-2029)
7 SEGMENT BY APPLICATION
7.1 Global Ketorolac Injection Sales by Application (2018-2029)
7.1.1 Global Ketorolac Injection Sales by Application (2018-2029) & (K Units)
7.1.2 Global Ketorolac Injection Sales Market Share by Application (2018-2029)
7.2 Global Ketorolac Injection Revenue by Application (2018-2029)
6.2.1 Global Ketorolac Injection Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Ketorolac Injection Revenue Market Share by Application (2018-2029)
7.3 Global Ketorolac Injection Price by Application (2018-2029)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Ketorolac Injection Value Chain Analysis
8.1.1 Ketorolac Injection Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Ketorolac Injection Production Mode & Process
8.2 Ketorolac Injection Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Ketorolac Injection Distributors
8.2.3 Ketorolac Injection Customers
9 GLOBAL KETOROLAC INJECTION ANALYZING MARKET DYNAMICS
9.1 Ketorolac Injection Industry Trends
9.2 Ketorolac Injection Industry Drivers
9.3 Ketorolac Injection Industry Opportunities and Challenges
9.4 Ketorolac Injection Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Ketorolac Injection Market Size (2018-2029) & (US$ Million)
2.2.2 Global Ketorolac Injection Sales (2018-2029)
2.2.3 Global Ketorolac Injection Market Average Price (2018-2029)
2.3 Ketorolac Injection by Concentration
2.3.1 Market Value Comparison by Concentration (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 15mg/ml
1.2.3 30mg/ml
2.4 Ketorolac Injection by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Hospital
2.4.3 Clinics
2.4.4 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Ketorolac Injection Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Ketorolac Injection Sales (K Units) of Manufacturers (2018-2023)
3.3 Global Ketorolac Injection Revenue of Manufacturers (2018-2023)
3.4 Global Ketorolac Injection Average Price by Manufacturers (2018-2023)
3.5 Global Ketorolac Injection Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Ketorolac Injection, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Ketorolac Injection, Product Type & Application
3.8 Global Manufacturers of Ketorolac Injection, Date of Enter into This Industry
3.9 Global Ketorolac Injection Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Pfizer
4.1.1 Pfizer Company Information
4.1.2 Pfizer Business Overview
4.1.3 Pfizer Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Pfizer Ketorolac Injection Product Portfolio
4.1.5 Pfizer Recent Developments
4.2 Fresenius Kabi
4.2.1 Fresenius Kabi Company Information
4.2.2 Fresenius Kabi Business Overview
4.2.3 Fresenius Kabi Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Fresenius Kabi Ketorolac Injection Product Portfolio
4.2.5 Fresenius Kabi Recent Developments
4.3 Fosun Pharma (Gland Pharma)
4.3.1 Fosun Pharma (Gland Pharma) Company Information
4.3.2 Fosun Pharma (Gland Pharma) Business Overview
4.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio
4.3.5 Fosun Pharma (Gland Pharma) Recent Developments
4.4 Sagent Pharmaceuticals
4.4.1 Sagent Pharmaceuticals Company Information
4.4.2 Sagent Pharmaceuticals Business Overview
4.4.3 Sagent Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Sagent Pharmaceuticals Ketorolac Injection Product Portfolio
4.4.5 Sagent Pharmaceuticals Recent Developments
4.5 Hikma
4.5.1 Hikma Company Information
4.5.2 Hikma Business Overview
4.5.3 Hikma Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hikma Ketorolac Injection Product Portfolio
6.5.5 Hikma Recent Developments
4.6 Lunan Pharma
4.6.1 Lunan Pharma Company Information
4.6.2 Lunan Pharma Business Overview
4.6.3 Lunan Pharma Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Lunan Pharma Ketorolac Injection Product Portfolio
4.6.5 Lunan Pharma Recent Developments
4.7 Alvogen
4.7.1 Alvogen Company Information
4.7.2 Alvogen Business Overview
4.7.3 Alvogen Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Alvogen Ketorolac Injection Product Portfolio
4.7.5 Alvogen Recent Developments
6.8 Chengdu Brilliant Pharmaceuticals
4.8.1 Chengdu Brilliant Pharmaceuticals Company Information
4.8.2 Chengdu Brilliant Pharmaceuticals Business Overview
4.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio
4.8.5 Chengdu Brilliant Pharmaceuticals Recent Developments
4.9 Athenex
4.9.1 Athenex Company Information
4.9.2 Athenex Business Overview
4.9.3 Athenex Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Athenex Ketorolac Injection Product Portfolio
4.9.5 Athenex Recent Developments
4.10 Sichuan Medcalo
4.10.1 Sichuan Medcalo Company Information
4.10.2 Sichuan Medcalo Business Overview
4.10.3 Sichuan Medcalo Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Sichuan Medcalo Ketorolac Injection Product Portfolio
4.10.5 Sichuan Medcalo Recent Developments
6.11 Julphar Bangladesh Ltd.
6.11.1 Julphar Bangladesh Ltd. Company Information
6.11.2 Julphar Bangladesh Ltd. Ketorolac Injection Business Overview
6.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio
6.11.5 Julphar Bangladesh Ltd. Recent Developments
6.12 Yung Shin Pharm
6.12.1 Yung Shin Pharm Company Information
6.12.2 Yung Shin Pharm Ketorolac Injection Business Overview
6.12.3 Yung Shin Pharm Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Yung Shin Pharm Ketorolac Injection Product Portfolio
6.12.5 Yung Shin Pharm Recent Developments
6.13 Tianjin Chase Sun Pharmaceutical
6.13.1 Tianjin Chase Sun Pharmaceutical Company Information
6.13.2 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Business Overview
6.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio
6.13.5 Tianjin Chase Sun Pharmaceutical Recent Developments
6.14 ZISKA Pharmaceuticals
6.14.1 ZISKA Pharmaceuticals Company Information
6.14.2 ZISKA Pharmaceuticals Ketorolac Injection Business Overview
6.14.3 ZISKA Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio
6.14.5 ZISKA Pharmaceuticals Recent Developments
5 GLOBAL KETOROLAC INJECTION MARKET SCENARIO BY REGION
5.1 Global Ketorolac Injection Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Ketorolac Injection Sales by Region: 2018-2029
5.2.1 Global Ketorolac Injection Sales by Region: 2018-2023
5.2.2 Global Ketorolac Injection Sales by Region: 2024-2029
5.3 Global Ketorolac Injection Revenue by Region: 2018-2029
5.3.1 Global Ketorolac Injection Revenue by Region: 2018-2023
5.3.2 Global Ketorolac Injection Revenue by Region: 2024-2029
5.4 North America Ketorolac Injection Market Facts & Figures by Country
5.4.1 North America Ketorolac Injection Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Ketorolac Injection Sales by Country (2018-2029)
5.4.3 North America Ketorolac Injection Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Ketorolac Injection Market Facts & Figures by Country
5.5.1 Europe Ketorolac Injection Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Ketorolac Injection Sales by Country (2018-2029)
5.5.3 Europe Ketorolac Injection Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Ketorolac Injection Market Facts & Figures by Country
5.6.1 Asia Pacific Ketorolac Injection Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Ketorolac Injection Sales by Country (2018-2029)
5.6.3 Asia Pacific Ketorolac Injection Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Ketorolac Injection Market Facts & Figures by Country
5.7.1 Latin America Ketorolac Injection Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Ketorolac Injection Sales by Country (2018-2029)
5.7.3 Latin America Ketorolac Injection Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Ketorolac Injection Market Facts & Figures by Country
5.8.1 Middle East and Africa Ketorolac Injection Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Ketorolac Injection Sales by Country (2018-2029)
5.8.3 Middle East and Africa Ketorolac Injection Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY CONCENTRATION
6.1 Global Ketorolac Injection Sales by Concentration (2018-2029)
6.1.1 Global Ketorolac Injection Sales by Concentration (2018-2029) & (K Units)
6.1.2 Global Ketorolac Injection Sales Market Share by Concentration (2018-2029)
6.2 Global Ketorolac Injection Revenue by Concentration (2018-2029)
6.2.1 Global Ketorolac Injection Sales by Concentration (2018-2029) & (US$ Million)
6.2.2 Global Ketorolac Injection Revenue Market Share by Concentration (2018-2029)
6.3 Global Ketorolac Injection Price by Concentration (2018-2029)
7 SEGMENT BY APPLICATION
7.1 Global Ketorolac Injection Sales by Application (2018-2029)
7.1.1 Global Ketorolac Injection Sales by Application (2018-2029) & (K Units)
7.1.2 Global Ketorolac Injection Sales Market Share by Application (2018-2029)
7.2 Global Ketorolac Injection Revenue by Application (2018-2029)
6.2.1 Global Ketorolac Injection Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Ketorolac Injection Revenue Market Share by Application (2018-2029)
7.3 Global Ketorolac Injection Price by Application (2018-2029)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Ketorolac Injection Value Chain Analysis
8.1.1 Ketorolac Injection Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Ketorolac Injection Production Mode & Process
8.2 Ketorolac Injection Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Ketorolac Injection Distributors
8.2.3 Ketorolac Injection Customers
9 GLOBAL KETOROLAC INJECTION ANALYZING MARKET DYNAMICS
9.1 Ketorolac Injection Industry Trends
9.2 Ketorolac Injection Industry Drivers
9.3 Ketorolac Injection Industry Opportunities and Challenges
9.4 Ketorolac Injection Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Concentration (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Ketorolac Injection Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Ketorolac Injection Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Ketorolac Injection Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Ketorolac Injection Revenue of Manufacturers (2018-2023)
Table 9. Global Ketorolac Injection Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Ketorolac Injection Average Price (US$/K Units) of Manufacturers (2018-2023)
Table 11. Global Ketorolac Injection Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Ketorolac Injection, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ketorolac Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Pfizer Company Information
Table 17. Pfizer Business Overview
Table 18. Pfizer Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 19. Pfizer Ketorolac Injection Product Portfolio
Table 20. Pfizer Recent Developments
Table 21. Fresenius Kabi Company Information
Table 22. Fresenius Kabi Business Overview
Table 23. Fresenius Kabi Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 24. Fresenius Kabi Ketorolac Injection Product Portfolio
Table 25. Fresenius Kabi Recent Developments
Table 26. Fosun Pharma (Gland Pharma) Company Information
Table 27. Fosun Pharma (Gland Pharma) Business Overview
Table 28. Fosun Pharma (Gland Pharma) Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 29. Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio
Table 30. Fosun Pharma (Gland Pharma) Recent Developments
Table 31. Sagent Pharmaceuticals Company Information
Table 32. Sagent Pharmaceuticals Business Overview
Table 33. Sagent Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 34. Sagent Pharmaceuticals Ketorolac Injection Product Portfolio
Table 35. Sagent Pharmaceuticals Recent Developments
Table 36. Hikma Company Information
Table 37. Hikma Business Overview
Table 38. Hikma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 39. Hikma Ketorolac Injection Product Portfolio
Table 40. Hikma Recent Developments
Table 41. Lunan Pharma Company Information
Table 42. Lunan Pharma Business Overview
Table 43. Lunan Pharma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 44. Lunan Pharma Ketorolac Injection Product Portfolio
Table 45. Lunan Pharma Recent Developments
Table 46. Alvogen Company Information
Table 47. Alvogen Business Overview
Table 48. Alvogen Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 49. Alvogen Ketorolac Injection Product Portfolio
Table 50. Alvogen Recent Developments
Table 51. Chengdu Brilliant Pharmaceuticals Company Information
Table 52. Chengdu Brilliant Pharmaceuticals Business Overview
Table 53. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 54. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio
Table 55. Chengdu Brilliant Pharmaceuticals Recent Developments
Table 56. Athenex Company Information
Table 57. Athenex Business Overview
Table 58. Athenex Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 59. Athenex Ketorolac Injection Product Portfolio
Table 60. Athenex Recent Developments
Table 61. Sichuan Medcalo Company Information
Table 62. Sichuan Medcalo Business Overview
Table 63. Sichuan Medcalo Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 64. Sichuan Medcalo Ketorolac Injection Product Portfolio
Table 65. Sichuan Medcalo Recent Developments
Table 66. Julphar Bangladesh Ltd. Company Information
Table 67. Julphar Bangladesh Ltd. Business Overview
Table 68. Julphar Bangladesh Ltd. Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 69. Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio
Table 70. Julphar Bangladesh Ltd. Recent Developments
Table 71. Yung Shin Pharm Company Information
Table 72. Yung Shin Pharm Business Overview
Table 73. Yung Shin Pharm Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 74. Yung Shin Pharm Ketorolac Injection Product Portfolio
Table 75. Yung Shin Pharm Recent Developments
Table 76. Tianjin Chase Sun Pharmaceutical Company Information
Table 77. Tianjin Chase Sun Pharmaceutical Business Overview
Table 78. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 79. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio
Table 80. Tianjin Chase Sun Pharmaceutical Recent Developments
Table 81. ZISKA Pharmaceuticals Company Information
Table 82. ZISKA Pharmaceuticals Business Overview
Table 83. ZISKA Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 84. ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio
Table 85. ZISKA Pharmaceuticals Recent Developments
Table 86. Global Ketorolac Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 87. Global Ketorolac Injection Sales by Region (2018-2023) & (K Units)
Table 88. Global Ketorolac Injection Sales Market Share by Region (2018-2023)
Table 89. Global Ketorolac Injection Sales by Region (2024-2029) & (K Units)
Table 90. Global Ketorolac Injection Sales Market Share by Region (2024-2029)
Table 91. Global Ketorolac Injection Revenue by Region (2018-2023) & (US$ Million)
Table 92. Global Ketorolac Injection Revenue Market Share by Region (2018-2023)
Table 93. Global Ketorolac Injection Revenue by Region (2024-2029) & (US$ Million)
Table 94. Global Ketorolac Injection Revenue Market Share by Region (2024-2029)
Table 95. North America Ketorolac Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. North America Ketorolac Injection Sales by Country (2018-2023) & (K Units)
Table 97. North America Ketorolac Injection Sales by Country (2024-2029) & (K Units)
Table 98. North America Ketorolac Injection Revenue by Country (2018-2023) & (US$ Million)
Table 99. North America Ketorolac Injection Revenue by Country (2024-2029) & (US$ Million)
Table 100. Europe Ketorolac Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Europe Ketorolac Injection Sales by Country (2018-2023) & (K Units)
Table 102. Europe Ketorolac Injection Sales by Country (2024-2029) & (K Units)
Table 103. Europe Ketorolac Injection Revenue by Country (2018-2023) & (US$ Million)
Table 104. Europe Ketorolac Injection Revenue by Country (2024-2029) & (US$ Million)
Table 105. Asia Pacific Ketorolac Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Asia Pacific Ketorolac Injection Sales by Country (2018-2023) & (K Units)
Table 107. Asia Pacific Ketorolac Injection Sales by Country (2024-2029) & (K Units)
Table 108. Asia Pacific Ketorolac Injection Revenue by Country (2018-2023) & (US$ Million)
Table 109. Asia Pacific Ketorolac Injection Revenue by Country (2024-2029) & (US$ Million)
Table 110. Latin America Ketorolac Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Latin America Ketorolac Injection Sales by Country (2018-2023) & (K Units)
Table 112. Latin America Ketorolac Injection Sales by Country (2024-2029) & (K Units)
Table 113. Latin America Ketorolac Injection Revenue by Country (2018-2023) & (US$ Million)
Table 114. Latin America Ketorolac Injection Revenue by Country (2024-2029) & (US$ Million)
Table 115. Middle East and Africa Ketorolac Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. Middle East and Africa Ketorolac Injection Sales by Country (2018-2023) & (K Units)
Table 117. Middle East and Africa Ketorolac Injection Sales by Country (2024-2029) & (K Units)
Table 118. Middle East and Africa Ketorolac Injection Revenue by Country (2018-2023) & (US$ Million)
Table 119. Middle East and Africa Ketorolac Injection Revenue by Country (2024-2029) & (US$ Million)
Table 120. Global Ketorolac Injection Sales by Concentration (2018-2023) & (K Units)
Table 121. Global Ketorolac Injection Sales by Concentration (2024-2029) & (K Units)
Table 122. Global Ketorolac Injection Sales Market Share by Concentration (2018-2023)
Table 123. Global Ketorolac Injection Sales Market Share by Concentration (2024-2029)
Table 124. Global Ketorolac Injection Revenue by Concentration (2018-2023) & (US$ Million)
Table 125. Global Ketorolac Injection Revenue by Concentration (2024-2029) & (US$ Million)
Table 126. Global Ketorolac Injection Revenue Market Share by Concentration (2018-2023)
Table 127. Global Ketorolac Injection Revenue Market Share by Concentration (2024-2029)
Table 128. Global Ketorolac Injection Price by Concentration (2018-2023) & (US$/K Units)
Table 129. Global Ketorolac Injection Price by Concentration (2024-2029) & (US$/K Units)
Table 130. Global Ketorolac Injection Sales by Application (2018-2023) & (K Units)
Table 131. Global Ketorolac Injection Sales by Application (2024-2029) & (K Units)
Table 132. Global Ketorolac Injection Sales Market Share by Application (2018-2023)
Table 133. Global Ketorolac Injection Sales Market Share by Application (2024-2029)
Table 134. Global Ketorolac Injection Revenue by Application (2018-2023) & (US$ Million)
Table 135. Global Ketorolac Injection Revenue by Application (2024-2029) & (US$ Million)
Table 136. Global Ketorolac Injection Revenue Market Share by Application (2018-2023)
Table 137. Global Ketorolac Injection Revenue Market Share by Application (2024-2029)
Table 138. Global Ketorolac Injection Price by Application (2018-2023) & (US$/K Units)
Table 139. Global Ketorolac Injection Price by Application (2024-2029) & (US$/K Units)
Table 140. Key Raw Materials
Table 141. Raw Materials Key Suppliers
Table 142. Ketorolac Injection Distributors List
Table 143. Ketorolac Injection Customers List
Table 144. Ketorolac Injection Industry Trends
Table 145. Ketorolac Injection Industry Drivers
Table 146. Ketorolac Injection Industry Restraints
Table 147. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Concentration (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Ketorolac Injection Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Ketorolac Injection Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Ketorolac Injection Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Ketorolac Injection Revenue of Manufacturers (2018-2023)
Table 9. Global Ketorolac Injection Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Ketorolac Injection Average Price (US$/K Units) of Manufacturers (2018-2023)
Table 11. Global Ketorolac Injection Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Ketorolac Injection, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ketorolac Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Pfizer Company Information
Table 17. Pfizer Business Overview
Table 18. Pfizer Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 19. Pfizer Ketorolac Injection Product Portfolio
Table 20. Pfizer Recent Developments
Table 21. Fresenius Kabi Company Information
Table 22. Fresenius Kabi Business Overview
Table 23. Fresenius Kabi Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 24. Fresenius Kabi Ketorolac Injection Product Portfolio
Table 25. Fresenius Kabi Recent Developments
Table 26. Fosun Pharma (Gland Pharma) Company Information
Table 27. Fosun Pharma (Gland Pharma) Business Overview
Table 28. Fosun Pharma (Gland Pharma) Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 29. Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio
Table 30. Fosun Pharma (Gland Pharma) Recent Developments
Table 31. Sagent Pharmaceuticals Company Information
Table 32. Sagent Pharmaceuticals Business Overview
Table 33. Sagent Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 34. Sagent Pharmaceuticals Ketorolac Injection Product Portfolio
Table 35. Sagent Pharmaceuticals Recent Developments
Table 36. Hikma Company Information
Table 37. Hikma Business Overview
Table 38. Hikma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 39. Hikma Ketorolac Injection Product Portfolio
Table 40. Hikma Recent Developments
Table 41. Lunan Pharma Company Information
Table 42. Lunan Pharma Business Overview
Table 43. Lunan Pharma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 44. Lunan Pharma Ketorolac Injection Product Portfolio
Table 45. Lunan Pharma Recent Developments
Table 46. Alvogen Company Information
Table 47. Alvogen Business Overview
Table 48. Alvogen Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 49. Alvogen Ketorolac Injection Product Portfolio
Table 50. Alvogen Recent Developments
Table 51. Chengdu Brilliant Pharmaceuticals Company Information
Table 52. Chengdu Brilliant Pharmaceuticals Business Overview
Table 53. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 54. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio
Table 55. Chengdu Brilliant Pharmaceuticals Recent Developments
Table 56. Athenex Company Information
Table 57. Athenex Business Overview
Table 58. Athenex Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 59. Athenex Ketorolac Injection Product Portfolio
Table 60. Athenex Recent Developments
Table 61. Sichuan Medcalo Company Information
Table 62. Sichuan Medcalo Business Overview
Table 63. Sichuan Medcalo Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 64. Sichuan Medcalo Ketorolac Injection Product Portfolio
Table 65. Sichuan Medcalo Recent Developments
Table 66. Julphar Bangladesh Ltd. Company Information
Table 67. Julphar Bangladesh Ltd. Business Overview
Table 68. Julphar Bangladesh Ltd. Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 69. Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio
Table 70. Julphar Bangladesh Ltd. Recent Developments
Table 71. Yung Shin Pharm Company Information
Table 72. Yung Shin Pharm Business Overview
Table 73. Yung Shin Pharm Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 74. Yung Shin Pharm Ketorolac Injection Product Portfolio
Table 75. Yung Shin Pharm Recent Developments
Table 76. Tianjin Chase Sun Pharmaceutical Company Information
Table 77. Tianjin Chase Sun Pharmaceutical Business Overview
Table 78. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 79. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio
Table 80. Tianjin Chase Sun Pharmaceutical Recent Developments
Table 81. ZISKA Pharmaceuticals Company Information
Table 82. ZISKA Pharmaceuticals Business Overview
Table 83. ZISKA Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 84. ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio
Table 85. ZISKA Pharmaceuticals Recent Developments
Table 86. Global Ketorolac Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 87. Global Ketorolac Injection Sales by Region (2018-2023) & (K Units)
Table 88. Global Ketorolac Injection Sales Market Share by Region (2018-2023)
Table 89. Global Ketorolac Injection Sales by Region (2024-2029) & (K Units)
Table 90. Global Ketorolac Injection Sales Market Share by Region (2024-2029)
Table 91. Global Ketorolac Injection Revenue by Region (2018-2023) & (US$ Million)
Table 92. Global Ketorolac Injection Revenue Market Share by Region (2018-2023)
Table 93. Global Ketorolac Injection Revenue by Region (2024-2029) & (US$ Million)
Table 94. Global Ketorolac Injection Revenue Market Share by Region (2024-2029)
Table 95. North America Ketorolac Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. North America Ketorolac Injection Sales by Country (2018-2023) & (K Units)
Table 97. North America Ketorolac Injection Sales by Country (2024-2029) & (K Units)
Table 98. North America Ketorolac Injection Revenue by Country (2018-2023) & (US$ Million)
Table 99. North America Ketorolac Injection Revenue by Country (2024-2029) & (US$ Million)
Table 100. Europe Ketorolac Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Europe Ketorolac Injection Sales by Country (2018-2023) & (K Units)
Table 102. Europe Ketorolac Injection Sales by Country (2024-2029) & (K Units)
Table 103. Europe Ketorolac Injection Revenue by Country (2018-2023) & (US$ Million)
Table 104. Europe Ketorolac Injection Revenue by Country (2024-2029) & (US$ Million)
Table 105. Asia Pacific Ketorolac Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Asia Pacific Ketorolac Injection Sales by Country (2018-2023) & (K Units)
Table 107. Asia Pacific Ketorolac Injection Sales by Country (2024-2029) & (K Units)
Table 108. Asia Pacific Ketorolac Injection Revenue by Country (2018-2023) & (US$ Million)
Table 109. Asia Pacific Ketorolac Injection Revenue by Country (2024-2029) & (US$ Million)
Table 110. Latin America Ketorolac Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Latin America Ketorolac Injection Sales by Country (2018-2023) & (K Units)
Table 112. Latin America Ketorolac Injection Sales by Country (2024-2029) & (K Units)
Table 113. Latin America Ketorolac Injection Revenue by Country (2018-2023) & (US$ Million)
Table 114. Latin America Ketorolac Injection Revenue by Country (2024-2029) & (US$ Million)
Table 115. Middle East and Africa Ketorolac Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. Middle East and Africa Ketorolac Injection Sales by Country (2018-2023) & (K Units)
Table 117. Middle East and Africa Ketorolac Injection Sales by Country (2024-2029) & (K Units)
Table 118. Middle East and Africa Ketorolac Injection Revenue by Country (2018-2023) & (US$ Million)
Table 119. Middle East and Africa Ketorolac Injection Revenue by Country (2024-2029) & (US$ Million)
Table 120. Global Ketorolac Injection Sales by Concentration (2018-2023) & (K Units)
Table 121. Global Ketorolac Injection Sales by Concentration (2024-2029) & (K Units)
Table 122. Global Ketorolac Injection Sales Market Share by Concentration (2018-2023)
Table 123. Global Ketorolac Injection Sales Market Share by Concentration (2024-2029)
Table 124. Global Ketorolac Injection Revenue by Concentration (2018-2023) & (US$ Million)
Table 125. Global Ketorolac Injection Revenue by Concentration (2024-2029) & (US$ Million)
Table 126. Global Ketorolac Injection Revenue Market Share by Concentration (2018-2023)
Table 127. Global Ketorolac Injection Revenue Market Share by Concentration (2024-2029)
Table 128. Global Ketorolac Injection Price by Concentration (2018-2023) & (US$/K Units)
Table 129. Global Ketorolac Injection Price by Concentration (2024-2029) & (US$/K Units)
Table 130. Global Ketorolac Injection Sales by Application (2018-2023) & (K Units)
Table 131. Global Ketorolac Injection Sales by Application (2024-2029) & (K Units)
Table 132. Global Ketorolac Injection Sales Market Share by Application (2018-2023)
Table 133. Global Ketorolac Injection Sales Market Share by Application (2024-2029)
Table 134. Global Ketorolac Injection Revenue by Application (2018-2023) & (US$ Million)
Table 135. Global Ketorolac Injection Revenue by Application (2024-2029) & (US$ Million)
Table 136. Global Ketorolac Injection Revenue Market Share by Application (2018-2023)
Table 137. Global Ketorolac Injection Revenue Market Share by Application (2024-2029)
Table 138. Global Ketorolac Injection Price by Application (2018-2023) & (US$/K Units)
Table 139. Global Ketorolac Injection Price by Application (2024-2029) & (US$/K Units)
Table 140. Key Raw Materials
Table 141. Raw Materials Key Suppliers
Table 142. Ketorolac Injection Distributors List
Table 143. Ketorolac Injection Customers List
Table 144. Ketorolac Injection Industry Trends
Table 145. Ketorolac Injection Industry Drivers
Table 146. Ketorolac Injection Industry Restraints
Table 147. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Ketorolac InjectionProduct Picture
Figure 5. Global Ketorolac Injection Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Ketorolac Injection Market Size (2018-2029) & (US$ Million)
Figure 7. Global Ketorolac Injection Sales (2018-2029) & (K Units)
Figure 8. Global Ketorolac Injection Average Price (US$/K Units) & (2018-2029)
Figure 9. 15mg/ml Product Picture
Figure 10. 30mg/ml Product Picture
Figure 11. Hospital Product Picture
Figure 12. Clinics Product Picture
Figure 13. Others Product Picture
Figure 14. Global Ketorolac Injection Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Ketorolac Injection, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Ketorolac Injection, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Ketorolac Injection Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Ketorolac Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Ketorolac Injection Sales by Region in 2022
Figure 21. Global Ketorolac Injection Revenue by Region in 2022
Figure 22. North America Ketorolac Injection Market Size by Country in 2022
Figure 23. North America Ketorolac Injection Sales Market Share by Country (2018-2029)
Figure 24. North America Ketorolac Injection Revenue Market Share by Country (2018-2029)
Figure 25. United States Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Ketorolac Injection Market Size by Country in 2022
Figure 28. Europe Ketorolac Injection Sales Market Share by Country (2018-2029)
Figure 29. Europe Ketorolac Injection Revenue Market Share by Country (2018-2029)
Figure 30. Germany Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Ketorolac Injection Market Size by Country in 2022
Figure 36. Asia Pacific Ketorolac Injection Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Ketorolac Injection Revenue Market Share by Country (2018-2029)
Figure 38. China Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Ketorolac Injection Market Size by Country in 2022
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Ketorolac InjectionProduct Picture
Figure 5. Global Ketorolac Injection Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Ketorolac Injection Market Size (2018-2029) & (US$ Million)
Figure 7. Global Ketorolac Injection Sales (2018-2029) & (K Units)
Figure 8. Global Ketorolac Injection Average Price (US$/K Units) & (2018-2029)
Figure 9. 15mg/ml Product Picture
Figure 10. 30mg/ml Product Picture
Figure 11. Hospital Product Picture
Figure 12. Clinics Product Picture
Figure 13. Others Product Picture
Figure 14. Global Ketorolac Injection Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Ketorolac Injection, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Ketorolac Injection, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Ketorolac Injection Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Ketorolac Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Ketorolac Injection Sales by Region in 2022
Figure 21. Global Ketorolac Injection Revenue by Region in 2022
Figure 22. North America Ketorolac Injection Market Size by Country in 2022
Figure 23. North America Ketorolac Injection Sales Market Share by Country (2018-2029)
Figure 24. North America Ketorolac Injection Revenue Market Share by Country (2018-2029)
Figure 25. United States Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Ketorolac Injection Market Size by Country in 2022
Figure 28. Europe Ketorolac Injection Sales Market Share by Country (2018-2029)
Figure 29. Europe Ketorolac Injection Revenue Market Share by Country (2018-2029)
Figure 30. Germany Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Ketorolac Injection Market Size by Country in 2022
Figure 36. Asia Pacific Ketorolac Injection Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Ketorolac Injection Revenue Market Share by Country (2018-2029)
Figure 38. China Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Ketorolac Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Ketorolac Injection Market Size by Country in 2022
